GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,776 | -70.4% | 49,870 | -58.3% | 0.00% | – |
| Q2 2022 | $290,000 | -13.2% | 119,645 | +47.6% | 0.00% | – |
| Q1 2022 | $334,000 | -48.0% | 81,064 | +62.3% | 0.00% | – |
| Q4 2021 | $642,000 | -70.1% | 49,932 | -74.9% | 0.00% | -100.0% |
| Q3 2021 | $2,149,000 | -71.2% | 198,924 | -75.6% | 0.00% | -75.0% |
| Q2 2021 | $7,451,000 | +3644.2% | 816,059 | +3772.2% | 0.00% | – |
| Q1 2021 | $199,000 | -61.5% | 21,075 | -84.0% | 0.00% | – |
| Q4 2020 | $517,000 | +27.3% | 131,363 | -14.2% | 0.00% | – |
| Q3 2020 | $406,000 | -51.1% | 153,086 | +22.3% | 0.00% | -100.0% |
| Q2 2020 | $831,000 | +151.1% | 125,167 | +120.2% | 0.00% | – |
| Q1 2020 | $331,000 | -35.5% | 56,849 | -0.9% | 0.00% | – |
| Q4 2019 | $513,000 | +27.6% | 57,357 | +22.7% | 0.00% | – |
| Q3 2019 | $402,000 | -7.2% | 46,748 | +19.7% | 0.00% | – |
| Q2 2019 | $433,000 | +13.6% | 39,070 | +36.0% | 0.00% | – |
| Q1 2019 | $381,000 | -15.0% | 28,729 | -1.1% | 0.00% | – |
| Q4 2018 | $448,000 | – | 29,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |